Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
LONDON (Alliance News) - Pharmaceutical giant GlaxoSmithKline PLC Friday said Chief Executive Officer Andrew Witty made several share transactions on May 1. Witty transferred by way of gift 500 shares in the company to each of his two children, and also sold 731 shares at 1,629.0550 pence e
Read more
* Pfizer bid fuels doubts over Astra's move to Cambridge * Astra planning new $500 mln research, corporate HQ by 2016 * UK wants Pfizer to commit to site, MPs to probe any deal (Adds comments from science minister, paragraphs 4-5) By Ben Hirschler CAMBRIDGE, England, May
Read more* Pfizer bid fuels doubts over Astra's move to Cambridge * Astra planning new $500 mln research, corporate HQ by 2016 * UK wants Pfizer to commit to site, MPs to probe any deal By Ben Hirschler CAMBRIDGE, England, May 1 (Reuters) - In Pfizer's $100 billion battle to win B
Read more
Domestic lender Lloyds rose into the top spot after saying that underlying profits rose by over a fifth in the first quarter and it continues to expect to apply to regulators in the second half to restart dividend payments. That came as it announced TSB bank is due to float in London before the end
Read moreLONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
GOLDMAN RAISES WILLIAM HILL PRICE TARGET TO 395 (385) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES WHITBREAD PRICE
The City is set to edge higher early on, tracking gains in the US last night which came after the much anticipated statement from the Federal Reserve, which held steady on its policy course with a few breezily positive remarks leading to a positive finish Stateside. Sources predict the FTSE 100 wi
Read moreDrugs giant GlaxoSmithKline on Thursday announced that the US Food and Drug Administration (FDA) has approved its Incruse medication known as Ellipta. Ellipta is used as a long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COP
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said FDA has approved Incruse Ellipta, or umeclidinium, as treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. Umeclidinium is GSK's first once-daily an
Read more* Lawmakers want to protect research and jobs in UK * Planned $100 bln bid would be biggest ever of a UK firm * Pfizer unable to commit on jobs or investment (Adds FT report on David Cameron's representatives in talks) By Kylie MacLellan and Ben Hirschler LONDON, April 3
Read moreBy Kate Kelland LONDON, April 30 (Reuters) - Leading British scientists called on the government on Wednesday to act now to save the nation's pharmaceutical industry from being swallowed up in a wave of consolidation driven by overseas rivals. In a statement prompted by a planned $100
Read moreLONDON (Alliance News) - The FTSE 100 closed marginally higher Wednesday, adding to gains posted on Monday and Tuesday, and ensuring that the blue-chip index closed the month of April firmly higher than it opened it.
Meanwhile, it was a volatile day in the forex market following a
* U.S. Advair sales drop 20 percent, China also weak * CEO says broad-based M&A deals "distracting" * Q1 sales 5.61 bln pounds vs consensus 5.84 bln * Q1 core EPS 21.0 pence vs consensus 20.7p * Shares down 2.4 percent, underperform FTSE 100 (Adds further analyst comment
Read moreHousebuilder Barratt Developments clawed back yesterday's losses, claiming its place in the top spot. Oil major Royal Dutch Shell rose strongly as first-quarter underlying earnings fell by 3% but beat expectations. Bottom-line earnings, however, were hit by £2.9bn of impairments in its Downstream
Read more* CEO says just "interested observer" in takeover battle * Witty views broad-based M&A deals as distracting * Sees "rational" case for investing in UK science By Ben Hirschler LONDON, April 30 (Reuters) - GlaxoSmithKline is just an "interested observer" as U.S. drugmaker P
Read moreLONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite
Read more
Last checked at